BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Apr 2026)
What this means for you
Registered since 14 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87982217
- Registration number
- 5962396
- Mark type
- Design + words
- Filed
- 09 May 2018
- Published for opposition
- 19 Feb 2019
- Registered
- 14 Jan 2020
- Attorney of record
- Scott W. Pink
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of acute and chronic infectious diseases; research and development in the pharmaceutical, life sciences and biotechnology fields
Owner
- BRII BIOSCIENCES LIMITED, San Mateo, CA, KY
- BRII BIOSCIENCES LIMITED, SHANGHAI, KY
- BRII BIOSCIENCES LIMITED, SHANGHAI, KY
- BiiG THERAPEUTICS LIMITED, SHANGHAI, KY
Prosecution history
- 02 Apr 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Apr 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Apr 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2026 — TEAS SECTION 8 & 15 RECEIVED
- 14 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Oct 2019 — DIVISIONAL PROCESSING COMPLETE
- 16 Oct 2019 — DIVISIONAL REQUEST RECEIVED
- 31 Oct 2019 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 30 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Oct 2019 — USE AMENDMENT FILED
- 16 Oct 2019 — TEAS REQUEST TO DIVIDE RECEIVED
- 30 Oct 2019 — SOU EXTENSION 1 GRANTED